Form 8-K - Current report:
SEC Accession No. 0001437749-25-001459
Filing Date
2025-01-21
Accepted
2025-01-21 09:41:24
Documents
16
Period of Report
2025-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20250120_8k.htm   iXBRL 8-K 30345
2 EXHIBIT 99.1 ex_767659.htm EX-99.1 13003
3 EXHIBIT 99.2 ex_767668.htm EX-99.2 19278
  Complete submission text file 0001437749-25-001459.txt   207271

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250113.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250113_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250113_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250113_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250120_8k_htm.xml XML 2840
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 25540831
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)